Evidence map›Paper›PMID 35666114›Full record

ReviewActa bio-medica : Atenei Parmensis2022

Obesity and COVID-19 in children and adolescents: a double pandemic.

Ilaria Brambilla, Francesco Delle Cave, Carmen Guarracino, Maria De Filippo, Martina Votto, Amelia Licari, Carmelo Pistone, Enrico Tondina

Open access · greenAbstract readReview
In one paragraph

Review in Acta bio-medica : Atenei Parmensis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. COVID-19 and diabetes in children.Annals of pediatric endocrinology & metabolism · 2022
    Article
  16. The Related Metabolic Diseases and Treatments of Obesity.Healthcare (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 4 countries.

Ilaria Brambillaa:1:{s:5:"en_US";s:39:"Fondazione IRCCS Policlinico San Matteo";}. i.brambilla@smatteo.pv.it.
Francesco Delle Cave. francesco.dellecave01@universitadipavia.it.
Carmen Guarracino. c.guarracino@smatteo.pv.it.
Maria De Filippo. maria_defilippo@hotmail.it.
Martina Votto. martina.votto@unipv.it.
Amelia Licari. amelia.licari@unipv.it.
Carmelo Pistone. c.pistone@smatteo.pv.it.
Enrico Tondina. enrico.tondina01@universitadipavia.it.
Institut Technique de l'Aviculture · FRMaria College · USMartin University · USMuseo Egizio · ITPoliclinico San Matteo Fondazione · ITStone Mountain Technologies (United States) · USUniversidad Nacional Intercultural de la Amazonía · PEUniversità Campus Bio-Medico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and aim of the studyThe high prevalence of obesity and obesity-related comorbidities has reached pandemic proportions, particularly in Western countries. It has been recently recognized as a significant risk factor in severe cases of COVID-19 in children and adolescents. Here, we summarize the existing knowledge regarding the pathophysiology of COVID-19 and consider how its various components may be exacerbated by the presence of obesity to investigate the impact of obesity on disease severity among patients with COVID-19 and collaborate for better clinical care of these patients.

methodsThe literature search was conducted from March 2020 to January 2022. A review of articles was performed via the online database PubMed, combining the terms "obesity," "weight gain," "COVID-19", "children."

resultsExcessive adipose tissue, insulin resistance, dyslipidemia, hypertension, high levels of proinflammatory cytokines are factors that compromise the functioning of organs and systems in obese patients. In obese patients with COVID-19 these changes can increase the risk of death, need for ventilatory assistance, risk of thromboembolism, and perpetuation of inflammatory response.

conclusionsObesity increases the risk for hospitalization, intensive care admission, mechanic ventilation requirement, and death among children and adolescents with COVID-19. These findings emphasize the need for effective actions by health professionals to increase awareness of the risks resulting from obesity and how these are heightened in the current global pandemic.

Indexed as

COVID-19AdolescentChildHospitalizationHumansObesityRisk FactorsSARS-CoV-2

Identifiers

PMID35666114
PMCPMC9494180
OpenAlexW4282928718

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.